Free Trial

Evoke Pharma (EVOK) Competitors

Evoke Pharma logo
$4.43 -0.16 (-3.49%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$4.56 +0.13 (+2.93%)
As of 07/25/2025 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EVOK vs. ENLV, FBLG, NRSN, OVID, SONN, RANI, NNVC, ALXO, TPST, and TENX

Should you be buying Evoke Pharma stock or one of its competitors? The main competitors of Evoke Pharma include Enlivex Therapeutics (ENLV), FibroBiologics (FBLG), NeuroSense Therapeutics (NRSN), Ovid Therapeutics (OVID), Sonnet BioTherapeutics (SONN), Rani Therapeutics (RANI), NanoViricides (NNVC), ALX Oncology (ALXO), Tempest Therapeutics (TPST), and Tenax Therapeutics (TENX). These companies are all part of the "pharmaceutical products" industry.

Evoke Pharma vs. Its Competitors

Enlivex Therapeutics (NASDAQ:ENLV) and Evoke Pharma (NASDAQ:EVOK) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

Enlivex Therapeutics has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Evoke Pharma has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500.

In the previous week, Enlivex Therapeutics had 1 more articles in the media than Evoke Pharma. MarketBeat recorded 3 mentions for Enlivex Therapeutics and 2 mentions for Evoke Pharma. Evoke Pharma's average media sentiment score of 0.93 beat Enlivex Therapeutics' score of 0.63 indicating that Evoke Pharma is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Enlivex Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Evoke Pharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Enlivex Therapeutics currently has a consensus target price of $10.00, suggesting a potential upside of 791.27%. Given Enlivex Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Enlivex Therapeutics is more favorable than Evoke Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enlivex Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Evoke Pharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

1.0% of Enlivex Therapeutics shares are owned by institutional investors. 12.3% of Enlivex Therapeutics shares are owned by company insiders. Comparatively, 2.3% of Evoke Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Enlivex Therapeutics has a net margin of 0.00% compared to Evoke Pharma's net margin of -43.80%. Enlivex Therapeutics' return on equity of -57.67% beat Evoke Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Enlivex TherapeuticsN/A -57.67% -50.52%
Evoke Pharma -43.80%-101.91%-33.75%

Evoke Pharma has higher revenue and earnings than Enlivex Therapeutics. Enlivex Therapeutics is trading at a lower price-to-earnings ratio than Evoke Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Enlivex TherapeuticsN/AN/A-$15.01M-$0.66-1.70
Evoke Pharma$10.25M0.64-$5.35M-$2.87-1.54

Summary

Enlivex Therapeutics beats Evoke Pharma on 11 of the 16 factors compared between the two stocks.

Get Evoke Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVOK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EVOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EVOK vs. The Competition

MetricEvoke PharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$6.61M$3.90B$5.75B$9.55B
Dividend YieldN/A1.21%4.71%4.01%
P/E Ratio-1.545.6720.8516.92
Price / Sales0.6411.99461.42104.42
Price / CashN/A6.4636.1858.54
Price / Book0.932.798.655.87
Net Income-$5.35M-$109.62M$3.25B$258.89M
7 Day Performance-2.85%5.55%4.30%3.70%
1 Month Performance67.80%12.34%10.57%11.71%
1 Year Performance-26.33%17.01%35.68%17.98%

Evoke Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EVOK
Evoke Pharma
1.2319 of 5 stars
$4.43
-3.5%
N/A-23.4%$6.61M$10.25M-1.544News Coverage
Gap Down
ENLV
Enlivex Therapeutics
2.7969 of 5 stars
$1.23
flat
$10.00
+713.0%
-19.3%$29.09MN/A-1.8670News Coverage
Analyst Forecast
Gap Up
FBLG
FibroBiologics
3.8053 of 5 stars
$0.72
+3.3%
$13.00
+1,705.6%
-85.8%$28.57MN/A-3.4310Positive News
Gap Up
NRSN
NeuroSense Therapeutics
2.7032 of 5 stars
$2.03
+2.5%
$14.00
+589.7%
+150.6%$27.75MN/A-3.7610
OVID
Ovid Therapeutics
4.7409 of 5 stars
$0.39
+6.0%
$3.13
+701.3%
-41.7%$27.73M$548K-1.1160
SONN
Sonnet BioTherapeutics
3.9574 of 5 stars
$8.61
-11.9%
$20.00
+132.3%
-41.3%$27.26M$1M0.0010Positive News
Gap Down
High Trading Volume
RANI
Rani Therapeutics
2.4887 of 5 stars
$0.41
-3.9%
$7.33
+1,688.6%
-81.5%$25.92M$1.03M-0.41110Positive News
Gap Up
High Trading Volume
NNVC
NanoViricides
0.3505 of 5 stars
$1.60
+9.6%
N/A-24.0%$25.72MN/A-2.2220High Trading Volume
ALXO
ALX Oncology
3.8437 of 5 stars
$0.47
+0.1%
$3.30
+606.6%
-91.4%$24.94MN/A-0.1940Positive News
TPST
Tempest Therapeutics
2.3277 of 5 stars
$6.67
-0.3%
$30.00
+349.8%
-65.3%$24.56MN/A-0.3720Positive News
TENX
Tenax Therapeutics
1.8027 of 5 stars
$5.85
-1.7%
$17.50
+199.1%
+82.2%$24.28MN/A-2.369Positive News

Related Companies and Tools


This page (NASDAQ:EVOK) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners